These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 25390018)

  • 1. Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR).
    Even SE; Dulak-Lis MG; Touyz RM; Nguyen Dinh Cat A
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):89-101. PubMed ID: 25390018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.
    Jia G; Aroor AR; Sowers JR
    Cardiovasc Res; 2017 Jul; 113(9):1055-1063. PubMed ID: 28838041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of perivascular adipose tissue on vascular homeostasis.
    Szasz T; Bomfim GF; Webb RC
    Vasc Health Risk Manag; 2013; 9():105-16. PubMed ID: 23576873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
    Whaley-Connell A; Johnson MS; Sowers JR
    Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Dysfunction in Obesity and Therapeutic Targets.
    Engin A
    Adv Exp Med Biol; 2024; 1460():489-538. PubMed ID: 39287863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human perivascular adipose tissue dysfunction as a cause of vascular disease: Focus on vascular tone and wall remodeling.
    Ozen G; Daci A; Norel X; Topal G
    Eur J Pharmacol; 2015 Nov; 766():16-24. PubMed ID: 26424111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses.
    Hoppmann J; Perwitz N; Meier B; Fasshauer M; Hadaschik D; Lehnert H; Klein J
    J Endocrinol; 2010 Feb; 204(2):153-64. PubMed ID: 19939912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
    Sowers JR; Whaley-Connell A; Epstein M
    Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease.
    Lastra G; Manrique C
    Horm Mol Biol Clin Investig; 2015 Apr; 22(1):19-26. PubMed ID: 25941914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
    Hirata A; Maeda N; Nakatsuji H; Hiuge-Shimizu A; Okada T; Funahashi T; Shimomura I
    Biochem Biophys Res Commun; 2012 Mar; 419(2):182-7. PubMed ID: 22326264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.
    Ronconi V; Turchi F; Appolloni G; di Tizio V; Boscaro M; Giacchetti G
    Curr Vasc Pharmacol; 2012 Mar; 10(2):238-46. PubMed ID: 22022770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and oxidative stress.
    Ando K; Fujita T
    Free Radic Biol Med; 2009 Aug; 47(3):213-8. PubMed ID: 19409982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.
    Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I
    Cardiovasc Res; 2009 Oct; 84(1):164-72. PubMed ID: 19505930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology.
    Armani A; Marzolla V; Fabbri A; Caprio M
    J Mol Endocrinol; 2015 Oct; 55(2):R1-10. PubMed ID: 26272942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoids in the heart and vasculature: new insights for old hormones.
    Lother A; Moser M; Bode C; Feldman RD; Hein L
    Annu Rev Pharmacol Toxicol; 2015; 55():289-312. PubMed ID: 25251996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between adipose tissue and vasculature: role of adiponectin.
    Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
    Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction.
    Gu P; Xu A
    Rev Endocr Metab Disord; 2013 Mar; 14(1):49-58. PubMed ID: 23283583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mineralocorticoid system, cardiometabolic health and its interplay with adipose tissue.
    Thuzar M; Abdul Halim M; Stowasser M
    J Endocrinol; 2024 Nov; 263(2):. PubMed ID: 39283910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose inflammation, insulin resistance, and cardiovascular disease.
    Shah A; Mehta N; Reilly MP
    JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.